67 studies found for:    "Pilocytic astrocytoma"
Show Display Options
Rank Status Study
21 Completed Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
Conditions: Brain and Central Nervous System Tumors;   Neuroblastoma
Interventions: Drug: carmustine;   Drug: irinotecan hydrochloride;   Procedure: surgical procedure;   Radiation: iodine I 131 monoclonal antibody 81C6
22 Withdrawn Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: magnetic resonance imaging;   Radiation: gadopentetate dimeglumine
23 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
24 Completed Imatinib Mesylate in Treating Patients With Gliomas
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
25 Completed Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Evaluating Patients Who Are Undergoing Treatment for Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: chemotherapy;   Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging;   Radiation: radiation therapy
26 Completed Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Radiation Toxicity
Intervention: Other: Questionnaire
27 Unknown  Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
28 Completed Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Dietary Supplement: calcitriol;   Drug: carboplatin
29 Completed Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: diagnostic laboratory biomarker analysis;   Other: immunoenzyme technique
30 Completed Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer
Intervention: Radiation: iodine I 131 monoclonal antibody 81C6
31 Unknown  Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: antineoplaston A10;   Drug: antineoplaston AS2-1
32 Completed Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: temozolomide
33 Withdrawn Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: conventional surgery;   Procedure: magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging
34 Completed Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: imatinib mesylate
35 Recruiting Temozolomide in Treating Patients With Low-Grade Glioma
Condition: CNS Tumor, Adult
Intervention: Drug: temozolomide
36 Completed Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Conditions: Brain and Central Nervous System Tumors;   Breast Cancer;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Lung Cancer;   Lymphoma;   Melanoma (Skin);   Neoplastic Syndrome
Intervention: Radiation: yttrium Y 90-edotreotide
37 Completed Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Procedure: biopsy;   Procedure: magnetic resonance imaging
38 Completed Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors
Conditions: Brain and Central Nervous System Tumors;   Metastatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: carboplatin;   Drug: tamoxifen citrate;   Drug: topotecan hydrochloride;   Other: pharmacological study
39 Unknown  Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: nucleic acid sequencing;   Other: diagnostic laboratory biomarker analysis;   Other: fluorine F 18 fluorothymidine;   Other: immunohistochemistry staining method;   Other: liquid chromatography;   Other: mass spectrometry;   Other: pharmacological study;   Procedure: adjuvant therapy;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: fludeoxyglucose F 18;   Radiation: intensity-modulated radiation therapy
40 Completed
Has Results
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
Condition: Cancer
Interventions: Drug: Fentanyl sublingual spray;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years